Vaccine trials are often done in wealthier countries. Scientists say the South Africa experience proves the value of trials in the global south.
from NYT > Top Stories https://ift.tt/38yJK2Y
https://ift.tt/eA8V8J
from NYT > Top Stories https://ift.tt/38yJK2Y
https://ift.tt/eA8V8J